Metoprolol Tartrate

CAS 56392-17-7 16 current records 13 historicalSmall Molecule

Who holds supplier records for Metoprolol Tartrate? 16 organisations hold a current record for Metoprolol Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), China (2), Netherlands (1), Spain (1) and 2 other countries (2).

Most records are filed under another form of this substance: Metoprolol Succinate (26 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Metoprolol Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/metoprolol-tartrate

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Metoprolol Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Metoprolol Tartrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Metoprolol Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
REINE LIFESCIENCE AnkleshwarIN
CEP 2025-269 - Rev 00
Metoprolol tartrate
Sept 2026—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2025-238 - Rev 01
Metoprolol tartrate, Process-II
Mar 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2007-057 - Rev 05
Metoprolol tartrate
Aug 2025—
TAPI NL B.V. AmsterdamNL
CEP 2001-240 - Rev 04
Metoprolol tartrate
Jul 2025—
SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L ReggelloIT
CEP 2004-087 - Rev 02
Metoprolol tartrate
Jul 2024Inspected Nov 2024
Italy
MICROSIN S.R.L. BucharestRO
CEP 2010-138 - Rev 01
Metoprolol tartrate
Jun 2024Inspected Jun 2023
Romania, outside 3-year window
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang CityCN
CEP 2016-193 - Rev 01
Metoprolol tartrate
Mar 2024—
Moehs Iberica S.L. RubiES
CEP 1996-021 - Rev 08
Metoprolol tartrate
Feb 2024—
IPCA Laboratories Limited MumbaiIN
R1-CEP 2003-091 - Rev 04
Metoprolol tartrate
Mar 2023—
MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor VillageIN
R0-CEP 2020-287 - Rev 01
Metoprolol tartrate
Jan 2023—
CTX LIFESCIENCES PVT. LIMITED SuratIN
R1-CEP 2009-260 - Rev 02
Metoprolol tartrate, Route I
Apr 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (13)

Organisations whose Type II DMFs for Metoprolol Tartrate are no longer active. These show a past filing, not current supply.

Show all 13 historical records
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 21865 · filed Sept 2008
  • POLYDRUG LABORATORIES PVT LTD
    Inactive DMF 21941 · filed Sept 2008
  • Italy · Inactive DMF 14324 · filed Jul 1999
  • SLOVAKOFARMA LTD
    Inactive DMF 11630 · filed Aug 1995
  • FREEDOM CHEMICAL DIAMALT GMBH
    Inactive DMF 9891 · filed Sept 1992
  • SYNCHEM CHEMICALS PRIVATE LTD
    Inactive DMF 9838 · filed Aug 1992
  • PLIVA CROATIA LTD
    Inactive DMF 9539 · filed Feb 1992
  • SIEGFRIED AG
    Inactive DMF 9110 · filed May 1991
  • RECORDATI INDUSTRIA CHIMICA SPA
    Inactive DMF 8838 · filed Nov 1990
  • NEWPORT PHARMACEUTICALS IRELAND
    Inactive DMF 8142 · filed Jul 1989
  • India · Inactive DMF 6599 · filed Oct 1986
  • Italy · Inactive DMF 6278 · filed Apr 1986
  • Italy · Inactive DMF 4819 · filed Dec 1982

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Metoprolol Tartrate is a beta-1 selective beta-blocker used primarily for the management of hypertension, angina pectoris, and heart failure. It works by decreasing the heart rate and myocardial contractility, leading to reduced cardiac output.

Chemical identity

IUPAC name
(2R,3R)-2,3-dihydroxybutanedioic acid;bis(1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol)
Canonical SMILES
CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChIKey
YGULWPYYGQCFMP-CEAXSRTFSA-N
Synonyms
Lopressor API, beloc, betaloc, cgp-2175e, lopresor, lopressor, metoprolol hemitartrate, metropress, nsc-757105, prelis, seloken, selopral

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

CardiovascularHypertensionAngina Pectoris

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Metoprolol Tartrate?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Metoprolol Tartrate: Ipca Laboratories Limited (India), TAPI NL BV (Netherlands), APITORIA PHARMA PRIVATE LTD (India), MOEHS IBERICA SL (Spain), MSN LIFE SCIENCES PRIVATE LIMITED (India), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (Italy), Sun Pharmaceutical Industries Limited (India) and Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. (China), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Metoprolol Tartrate Drug Master Files are active?

Ipca Laboratories Limited (DMF 21254, 15850), TAPI NL BV (DMF 6838, 7151), APITORIA PHARMA PRIVATE LTD (DMF 19283), MOEHS IBERICA SL (DMF 14907, 7306), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 34705), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (DMF 5605), Sun Pharmaceutical Industries Limited (DMF 15995) and Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. (DMF 24038) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Metoprolol Tartrate records mean?

13 organisations have only inactive Type II DMFs for Metoprolol Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Metoprolol Tartrate have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Metoprolol Tartrate on the EDQM register, including REINE LIFESCIENCE Ankleshwar (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), TAPI NL B.V. Amsterdam (NL), SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L Reggello (IT) and MICROSIN S.R.L. Bucharest (RO) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Metoprolol Tartrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Metoprolol Tartrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.